logo
Share SHARE
FONT-SIZE Plus   Neg

Granules India's Paracetamol API Facility Completes U.S. FDA Inspection

Granules India Ltd., a fast growing pharmaceutical manufacturing company, announced its Paracetamol facility successfully passed a US FDA inspection without any 483 observations. The facility has the world's largest single API production line by volume.

Granules' four API facilities have successfully passed US FDA inspection in the past 12 months. All of Granules' facilities including its finished dosage and PFI facility are approved by leading regulatory agencies including the US FDA, EDQM, Health Canada and Korean FDA.

At the BSE, Granules India shares are currently trading at Rs.397.50, up 0.33 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

0 Articles
Editors Pick
Uber has developed new software that will track and inform drivers of the ride-hailing app about things like sudden acceleration, harsh braking or whether they are holding their phones while driving. The software is part of an updated version of Uber's app for drivers. One third of its PlayStation Plus users pay for games, Sony revealed on Wednesday. Wal-Mart Stores Inc. is offering a free 30-day trial of its ShippingPass subscription program. In order to better compete with Amazon.com (AMZN), Wal-Mart has introduced the $49-a-year ShippingPass subscription service last year, which gives a user unlimited two-day shipping.
comments powered by Disqus
Follow RTT